Equilab International in Indonesia
E-mail: info@equilab-int.com; ronal.simanjuntak@equilab-int.com; mesulam.esther@equilab-int.com
Web: https://www.equilab-int.com/
Phone: +62 21 7695513
Address:
-
Jl. RS. Fatmawati Persil 33, Jakarta Selatan 12430, Indonesia
About Equilab International
Equilab International is the first CRO in Indonesia as well as the first CRO in South East Asia that got approval from WHO. They have established their end-to-end services for their customers from all around the globe, including the top multinational companies in pharmaceutical and biotechnology industry. Equilab is credible in managing clinical trials with thousands subjects in extensive study sites. They have strong experiences in vaccine, hormonal, nutritional, cardiovascular, endocrine, oncology, and dermatology clinical trials.
Equilab International actively engages with the regulatory authorities, with the local and also overseas FDA. They have proved that Material Transfer Agreement (MTA) approval is no longer an obstacle in conducting clinical research in Indonesia. They managed to get MTA approvals for their studies, followed by numerous samples shipment to Japan, China and India. In addition, their study reports have been approved in Europe (including the UK, Germany, Netherland, Poland, Spain, and Hungary), all ASEAN countries, China, Taiwan, Hong Kong, and some countries in Africa.
Having an accredited facility, Equilab International can also be your choice of central laboratory to support your clinical trials. It has both of clinical and analytical laboratories, equipped with at least 10 biomedical freezers (-20oC and -70oC) under a controlled automated system. The complete set of skillful operation team and acknowledged facility has made Equilab International become the leading CRO in Indonesia.